# Broadcare Robot

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/broadcare-robot

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.broadcare.com.cn
- Total disclosed funding: $7.3M
- Latest round: Series B (Aug 24, 2022)
- Investors on record: 2

## About

Based in Shenzhen, China and established in 2015, Broadcare Robot is a medical equipment company that focuses on research and development, production, clinical application and sales of intelligent medical systems and medical robots. The company's team members are from research institutions, such as the University of Hamburg, Harbin Institute of Technology, and the Chinese Academy of Sciences. Professor Jianwei, Zhang, academician of the Hamburg Academy of Sciences, Germany , works in Broadcare Robot as the chief scientist. The company is a national high-tech enterprise, which is also a major participant in many projects, such as Key Technologies and Demonstration Applications of Intelligent Nursing Robots, Shenzhen Basic Research. Broadcare Robot has applied for more than 50 domestic and foreign patents.

The company provides intelligent solution for hospital clinical infusion. Products within include desktop ampoule intravenous drug compounding robot, desktop vial intravenous drug dispensing robot, multi-functional intravenous drug compounding robot. Those product can be used in the scenes, such as pharmacy intravenous admixture services (PIVAS), chemotherapy dispensing room, hospital departments, pharmacies and consumables warehouses and have been clinically applied in more than 60 hospitals in many provinces such as Guangdong, Guangxi, Hunan, Jiangsu, Anhui, Sichuan and Shandong.

The company's revenue steams include sales of software and hardware products, and overall solution of smart intravenous drug dispensing. The software and hardware products priced from hundreds of thousands to millions RMB, and the smart intravenous drug dispensing solution priced from 10 million RMB level.

## Funding rounds

- Series B, Aug 24, 2022, $7.3M — Ken Capital
- Series B, Sep 2, 2019 — CASH Capital

## Investors

- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Series B
- Ken Capital (https://capitalatlas.ai/funds/ken-capital) — Series B